Compounds, compositions, and methods for controlling biofilms

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Biocides; animal or insect repellents or attractants

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S362000

Reexamination Certificate

active

07018642

ABSTRACT:
The present invention provides nitrogen heterocyclic compounds, compositions, and methods for controlling biofilms, i.e., disrupting biofilms, preventing biofilm formation, enhancing biofilms, or modifying biofilms. Methods for screening test compounds for control of biofilms and devices for use therein are also provided.

REFERENCES:
patent: 3852283 (1974-12-01), Dolfini et al.
patent: 4278681 (1981-07-01), Haskell et al.
patent: 4278789 (1981-07-01), Birkenmeyer
patent: 4782147 (1988-11-01), Ochiai et al.
patent: 4963548 (1990-10-01), Lunkenheimer et al.
patent: 5620953 (1997-04-01), Cannova et al.
patent: 5686486 (1997-11-01), Tomich et al.
patent: 5936065 (1999-08-01), Arrhenius et al.
patent: 6143776 (2000-11-01), Erlanson
patent: 6288091 (2001-09-01), Crute et al.
patent: 6326190 (2001-12-01), Ceri et al.
patent: 2001/0049975 (2001-12-01), Ceri et al.
patent: 0208279 (1987-01-01), None
patent: 0 220 939 (1987-05-01), None
patent: 0 294 667 (1988-12-01), None
patent: 0 346 847 (1989-12-01), None
patent: 0 541 497 (1993-05-01), None
patent: 0 587 311 (1994-03-01), None
patent: 1 038 972 (2000-09-01), None
patent: 1 160 236 (2001-12-01), None
patent: 52021322 (1977-02-01), None
patent: 08081488 (1996-03-01), None
patent: WO 8806885 (1988-09-01), None
patent: WO 9303055 (1993-02-01), None
patent: WO 9640752 (1996-12-01), None
patent: WO 9717958 (1997-05-01), None
patent: WO 9717963 (1997-05-01), None
patent: WO 97/33972 (1997-09-01), None
patent: WO 98/07883 (1998-02-01), None
patent: WO 9857618 (1998-12-01), None
patent: WO 9857932 (1998-12-01), None
patent: WO 9858075 (1998-12-01), None
patent: WO 9905227 (1999-02-01), None
patent: WO 9927786 (1999-06-01), None
patent: WO 9932428 (1999-07-01), None
patent: WO 9939704 (1999-08-01), None
patent: WO 99/43658 (1999-09-01), None
patent: WO 9955368 (1999-11-01), None
patent: WO 0006177 (2000-02-01), None
patent: WO 0028043 (2000-05-01), None
patent: WO 0032152 (2000-06-01), None
patent: WO 0132655 (2001-03-01), None
patent: WO 0144178 (2001-06-01), None
patent: WO 0144179 (2001-06-01), None
patent: WO 0214270 (2002-02-01), None
Ferreiro et al. “Assignment of the absolute . . . ” CA 133:4396 (2000).
Huang et al. “Absolute configurational . . . ” CA 137:294571 (2002).
Jain et al. “Alpha substituted hydroxamic acid . . . ” CA 140:128630 (2003).
McFeters et al. “Physiological methods to study biofilm disinfection” CA 124:25250 (1995).
Flemming et al. “Measures against biofoulihg” CA 126:300403 (1997).
Jass et al. “Biofilms and biofouling” CA 136:244074 (2002).
Chicurel M. “Slimebusters” Nature vol. 408 (16) p. 284-286 (2000).
Alcón, et al., “Rh and Ir complexes containing multidentate,C2-symmetry ligands. Structural and catalytic properties in asymmetric hydrogenation”, Journal of Organometallic Chemistry, vol. 601, pp. 284-292, (2000), Elsevier Science S.A.
Alcón, et al., “Synthesis of Rh(I) and Ir(I) complexes with chiral C2-multitopic ligands. Structural and catalytic properties”, Journal of Organometallic Chemistry, vol. 634, pp. 25-33, (2001), Elsevier Science B.V.
Birkenmeyer, et al., “Synthesis and Antimicrobial Activity of Clindamycin Analogues: Pirlimycin,1, 2a Potent Antibacterial Agent”, J. Med. Chem., vol. 27, pp. 216-223, (1984), American Chemical Society.
Brugger, M., “128. Synthesis von lipophil substituierten ACTH-Peptiden”, Helvetica Chimca Acta, vol. 54, pp. 1261-1274, (1971), Verlag Helvetica Chimca Acta. (English Abstract).
Bulacinski, et al., “Synthesis of acyclic and heterocyclic derivatives of 2-carboxyquinuclidine”, Acta Pol. Pharm., vol. 41, No. 3, pp. 313-317, (1984), American Chemical Society. (Abstract).
Bulacinski, et al., “Synthesis of acyclic and heterocyclic derivatives of 2-carboxyquinuclidine. II”, Acta Pol. Pharm., vol. 41, No. 4, pp. 441-446, (1984), American Chemical Society. (Abstract).
Charlet-Fagnère, et al., “Syntheses of Large-Ring Bis-Indolic Dilactams”, Tetrahedron Letters, vol. 40, pp. 1685-1688, (1999), Elsevier Science Ltd.
Chen, et al., “Synthesis of new substance P analogues releasing histamine from rat peritoneal mast cells”, Eur. J. Med. Chem., vol. 27, pp. 931-937, (1992), Elsevier.
Colleti, et al., “Broad Spectrum Antiprotozoal Agents that Inhibit Histone Deacetylase: Structure-Activity Relationships of Apicidin. Part 2”, Bioorganic & Medicinal Chemistry Letters, vol. 11, pp. 113-117, (2001), Elsevier Science Ltd.
Emmer, et al., “Derivatives of a Novel Cyclopeptolide. 1. Synthesis, Antifungal Activity, and Structure-Activity Relationships”, J. Med. Chem., vol. 37, pp. 1908-1917, (1994), American Chemical Society.
Estrada, et al., “In Silico Studies for the Rational Discovery of Anticonvulsant Compounds”, Bioorganic & Medicinal Chemistry Letters, vol. 8, pp. 2755-2770, (2000), Elsevier Science Ltd.
Ferreiro, et al., “Assignment of the Absolute Configuration of a α-Chiral Carboxylic Acids by1H NMR Spectroscopy”, J. Org. Chem., vol. 65, pp. 2658-2666, (2000), American Chemical Society.
Fujita, et al., “7-(2-Aminomethyl-1-azetidinyl)-4-oxoquinoline-3carboxylic Acids as Potent Antibacterial Agents: Design, Synthesis, and Antibacterial Activity”, Chem. Pharm. Bull., vol. vol. 46, No. 5, pp. 787-796, (1998), Pharmaceutical Society of Japan.
Haskell, et al., “Semisynthetic Penicillins. A Structure-Activity Study of a New Series of Acyl Amino Acid—Pyridone and Pyrimidone Amoxicillin Analogs”, The Journal of Antibiotics, pp. 862-868, (1981), Japan Antibiotics Research Association.
Haurou, et al., “Enantiomeric resolution of amino acid derivatives by high-performance liquid chromatography an chiral stationary phases derived from L-proline”, Journal of Chromatography, vol. 547, pp. 31-44, (1991), Elsevier Science Publishers B.V.
Hill, et al., “Photochemistry of Dipeptides in Aqueous Solution”, J. Am. Chem. Soc., vol. 113, pp. 1805-1817, (1991), American Chemical Society.
Hinko, et al., “Anticonvulsant activity of novel derivatives of 2- and 3-piperidinecarboxylic acid in mice and rats”, Neuropharmacology, vol. 35, No. 12, pp. 1721-1735, (1997), American Chemical Society. (Abstract).
Ho, et al., “Synthesis of 2-piperidinecarboxylic acid derivatives as potential anticonvulsants”, Eur. J. Med. Chem., vol. 33, pp. 23-31, (1998), Elsevier, Paris.
Hopkins, et al., “Synthesis and Structure of Chiral Macrocycles Containing 2,2′-Bipyridine Subunits”, Bioorganic & Medical Chemistry, vol. 4, No. 7, pp. 1121-1128, (1996), Elsevier Science Ltd.
Johnson, et al., “Dopamine Receptor Modulation by Pro—Leu—Gly—NH2Analogues Possessing Cyclic Amino Acid Residues at the C-Terminal Position”, J. Med. Chem., vol. 29, pp. 2100-2104, (1986), American Chemical Society.
Johnson, et al., “Synthesis of Pro—Leu—Gly—NH2Analogues Modified at the Prolyl Residue and Evaluation of Their Effects on the Receptor Binding Activity of the Central Dopamine Receptor Agonist, ADTN”, J. Med. Chem., vol. 29, pp. 2104-2107, (1986), American Chemical Society.
Jun, et al., “Stereochemistry of Complexes of Multidentate Ligands. III. Stereoselective Cobalt(III) Ion Complexes of 1,6-Bis(2(S)-pyrrolidyl)-2,5-diazahexane”, Inorganic Chemistry, vol. 14, No. 10, pp. 2310-2314, (1975), American Chemical Society.
Jun, et al., “Stereochemistry of Complexes of Multidenate Ligands. V. Steroselective Cobalt(III) Ion Complexes of N, N′-Bis(2-S-Pyrrolidymethyl)-trans-R-1,2-Cyclohexanediamine”, Inorganic Chimica Acta, vol. 15, pp. 111-116, (1975), Elsevier Sequoia S.A., Lausanne.
Kitagawa, et al., “New Nickel(II) Complexes of Some Optically Active Tetraamines with Pyrrolidinyl Groups”, Inorganic Chemistry, vol. 14, No. 10, pp. 2347-

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compounds, compositions, and methods for controlling biofilms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, compositions, and methods for controlling biofilms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, compositions, and methods for controlling biofilms will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3526068

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.